prikaz prve stranice dokumenta SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?
  Download
PDF 359.85 KB
Professional paper - Letter to the editor
SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?
British Journal of Clinical Pharmacology, 87 (2021), 11; 4476-4478. https://doi.org/10.1111/bcp.14849
Bošković, Marko; Migo, William; Likić, Robert

Linked objects
COVID-19 | Virtual collection

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Bošković, M., Migo, W. & Likić, R. (2021). SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?. British Journal of Clinical Pharmacology, 87. (11), 4476-4478. doi: 10.1111/bcp.14849

Bošković, Marko, et al. "SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?." British Journal of Clinical Pharmacology, vol. 87, no. 11, 2021, pp. 4476-4478. https://doi.org/10.1111/bcp.14849

Bošković, Marko, William Migo and Robert Likić. "SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?." British Journal of Clinical Pharmacology 87, no. 11 (2021): 4476-4478. https://doi.org/10.1111/bcp.14849

Bošković, M., Migo, W. and Likić, R. (2021) 'SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?', British Journal of Clinical Pharmacology, 87(11), pp. 4476-4478. doi: 10.1111/bcp.14849

Bošković M, Migo W, Likić R. SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?. British Journal of Clinical Pharmacology [Internet]. 2021 November [cited 2024 November 22];87(11):4476-4478. doi: 10.1111/bcp.14849

M. Bošković, W. Migo and R. Likić, "SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?", British Journal of Clinical Pharmacology, vol. 87, no. 11, pp. 4476-4478, November 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:329087. [Accessed: 22 November 2024]

Metadata
Title (english)SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?
AuthorMarko Bošković
AuthorWilliam Migo
AuthorRobert Likić
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Keywords (english)
Languageenglish
Publication typeProfessional paper - Letter to the editor
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleBritish Journal of Clinical Pharmacology
Numberingvol. 87, no. 11, pp. 4476-4478
p-ISSN0306-5251
e-ISSN1365-2125
DOIhttps://doi.org/10.1111/bcp.14849
URN:NBNurn:nbn:hr:105:329087
Publication2021-11
Document URLhttps://onlinelibrary.wiley.com/doi/10.1111/bcp.14849
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2021-12-09 12:18:15